Lotte Bjerre Knudsen

Lotte Bjerre Knudsen (born 10 March 1964) is a Danish scientist and university professor. She led the development of liraglutide and oversaw the development of semaglutide,[1][2] two notable drugs approved for indications in the treatment of diabetes and obesity.[2][3]

  1. ^ Molteni, Megan; Chen, Elaine (30 September 2023). "GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?" STAT News. [1]. "Some of the most compelling evidence for this came when Novo Nordisk began testing a once-weekly version developed by Knudsen’s team, called semaglutide. Whereas liraglutide has been shown to cut a person’s food intake by 15%, semaglutide reduced it by up to 35%."
  2. ^ a b Cite error: The named reference Spiegel was invoked but never defined (see the help page).
  3. ^ Knudsen, L. B. & Lau, J. (11 April 2019). "The Discovery and Development of Liraglutide and Semaglutide". Front. Endocrinol. 10: 155ff. doi:10.3389/fendo.2019.00155. ISSN 1664-2392. PMC 6474072. PMID 31031702.{{cite journal}}: CS1 maint: multiple names: authors list (link)